connective tissue disease: A disorder characterized by abnormalities in one or more of the elements of the connective tissues, typically associated with genetic defects.
Systemic disorders of connective tissue in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
M13_SYSTCONINOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
142 |
4. Check minimum number of eventsNone |
142 |
5. Include endpointsNone |
142 |
6. Filter based on genotype QC (FinnGen only) |
142 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Systemic disorders of connective tissue in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Other systemic involvement of connective tissue
- Systemic connective tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1422 | 617 | 803 |
| Only index persons | 1167 | 513 | 654 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 25.39 | 30.73 | 21.29 |
| Only index persons | 30.58 | 35.25 | 26.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 142 | 71 | 71 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 48.86 | 52.49 | 45.24 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 128
- Matched controls
- 1280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
+∞
42.0
38
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
30.4
28
*
D69.0
ICD-10 Finland
Allergic purpura
354.7
29.0
28
*
126
Kela drug reimbursment
Chronic coagulation defects
323.0
26.8
26
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
24.8
23
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.4
23.7
75
206
D66
ICD-10 Finland
Hereditary factor VIII deficiency
+∞
23.7
22
*
B02BD02
ATC
coagulation factor VIII; parenteral, topical, urethral
+∞
20.3
19
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
16.0
20.0
33
27
M362, D66
ICD-10 Finland
NA
+∞
19.2
18
*
ZX120
NOMESCO Finland
Intravenous
9.5
18.4
40
58
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
18.1
17
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
17.0
16
*
C90.0
ICD-10 Finland
Multiple myeloma
64.7
15.2
17
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
14.9
14
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
168.4
14.8
15
*
M36.2
ICD-10 Finland
Haemophilic arthropathy
+∞
13.8
13
*
2860A
ICD-9 Finland
Coagulation defects, Congenital factor VIII disorder
+∞
12.7
12
*
28600
ICD-8 Finland
Coagulation defects, Haemophilia
+∞
12.7
12
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
143.5
12.7
13
*
B02AA02
ATC
tranexamic acid; systemic
5.9
12.4
37
82
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
14.6
12.1
20
16
6BA02
NOMESCO Finland
NA
71.7
11.8
13
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.3
11.8
21
20
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
11.6
11
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
8.3
11.6
26
38
J01MA12
ATC
levofloxacin; systemic
4.8
11.6
43
121
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
22.6
11.5
16
8
R50.9
ICD-10 Finland
Fever, unspecified
5.0
11.4
40
106
M36.4
ICD-10 Finland
Arthropathy in hypersensitivity reactions classified elsewhere
+∞
10.6
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.9
10.5
37
98
H02AB07
ATC
prednisone; oral
5.2
10.1
33
80
B18.2
ICD-10 Finland
Chronic viral hepatitis C
22.2
10.0
14
7
H02AB06
ATC
prednisolone; systemic
3.4
9.9
72
353
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
9.7
71
347
R4110
NOMESCO Finland
Physiotherapy
3.7
9.6
52
201
ZX121
NOMESCO Finland
Central venous catheter
107.7
9.5
10
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
9.5
9
*
M05BA02
ATC
clodronic acid; systemic
+∞
9.5
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
9.0
43
150
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.3
8.9
18
22
J01FF01
ATC
clindamycin; systemic
3.5
8.8
50
199
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.6
8.6
17
20
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.1
8.6
14
11
L04AX04
ATC
lenalidomide; oral
96.1
8.5
9
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
96.1
8.5
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.4
8.5
26
58
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
7.2
8.4
20
32
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
8.1
26
61
A02BC02
ATC
pantoprazole; systemic
3.0
7.9
87
533
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.4
7.7
23
50
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.7
7.6
17
25
153
Kela drug reimbursment
Lenalidomid
84.8
7.5
8
*
N02AA05
ATC
oxycodone; systemic
4.2
7.4
29
84
J01MA14
ATC
moxifloxacin; systemic
5.3
7.3
22
48
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
9.7
7.3
14
16
C01CA24
ATC
epinephrine; parenteral
6.6
7.2
18
31
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
6.8
7.1
17
28
L04AX01
ATC
azathioprine; systemic
9.1
7.0
14
17
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
14.9
7.0
11
8
UJF30
NOMESCO Finland
Ileoscopy through colon
5.3
7.0
21
46
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.9
6.9
15
21
M05BA04
ATC
alendronic acid; oral
6.2
6.9
18
33
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
6.2
6.9
18
33
J05AB11
ATC
valaciclovir; oral
3.9
6.9
29
89
H02AB09
ATC
hydrocortisone; systemic
24.0
6.8
9
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.8
6.6
18
35
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
15.3
6.5
10
7
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.0
6.4
12
13
NF1AA
NOMESCO Finland
Hip X-ray examination
5.3
6.4
19
41
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
6.4
44
194
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.5
6.3
18
37
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
6.3
6
*
5BA08
NOMESCO Finland
NA
+∞
6.3
6
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
6.3
6
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
+∞
6.3
6
*
D67
ICD-10 Finland
Hereditary factor IX deficiency
+∞
6.3
6
*
N02AX02
ATC
tramadol; systemic, rectal
2.6
6.3
62
337
XW000
NOMESCO Finland
Bone marrow biopsy
7.3
6.2
14
21
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.3
6.1
22
59
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
31
33
11.74
27.22
1.5
1.2
g/l
0.2
0.2
0.19
31
33
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
31
35
11.05
26.08
1.5
1.2
g/l
1.2
1.2
0.22
31
35
(42870588) Differential panel, method unspecified - Blood
89
347
5.19
21.04
17.2
5.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
48
7.98
20.12
7.6
2.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
37
85
5.53
16.11
5.4
2.0
g/l
0.2
0.2
0.58
37
78
(3001604) Monocytes [#/volume] in Blood
106
543
4.76
16.00
19.0
5.8
e9/l
0.6
0.6
0.41
99
484
(3006315) Basophils [#/volume] in Blood
106
546
4.71
15.80
19.0
5.8
e9/l
0.0
0.0
0.15
99
484
(3023520) Reticulocytes [#/volume] in Blood
32
67
5.87
15.36
2.6
2.7
e9/l
80.5
67.6
0.62
18
49
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
63
6.02
15.35
3.8
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
107
563
4.65
15.29
18.9
5.8
e9/l
1.9
1.9
0.30
101
507
(3037522) Nuclear Ab [Titer] in Serum
42
114
4.81
14.97
1.7
1.4
titre
448.0
409.7
—
10
29
(3024561) Albumin [Mass/volume] in Serum or Plasma
89
417
4.04
14.88
10.5
4.2
g/l
35.2
35.9
0.45
84
396
(3013115) Eosinophils [#/volume] in Blood
106
561
4.51
14.84
19.5
5.9
e9/l
0.2
0.2
0.03
99
501
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
60
228
3.83
13.40
4.0
1.9
mg/l
3.0
3.1
0.30
52
190
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
19
9.36
12.62
3.6
1.6
—
—
—
0
0
(4306422)
15
17
9.75
12.23
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
17
9.75
12.23
4.5
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
23
8.26
12.12
2.2
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
79
4.74
11.75
5.0
3.4
ml/min/173m2
89.0
62.4
3.50
21
40
(3013650) Neutrophils [#/volume] in Blood by Automated count
110
655
4.01
11.70
22.2
9.2
e9/l
4.1
4.0
0.13
104
571
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
21
8.46
11.67
1.3
1.2
u/ml
2.4
7.6
—
10
9
(3007164) IgA [Mass/volume] in Serum or Plasma
63
267
3.44
11.61
4.5
1.4
g/l
2.4
2.4
0.02
42
155
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
25
7.59
11.28
3.3
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
25
7.59
11.28
3.6
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
14
10.12
10.93
6.5
1.6
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
10
0
+∞
10.54
2.7
0.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
15
9.44
10.40
6.5
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
124
3.82
10.31
3.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.84
10.28
4.5
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
10
11.84
10.28
4.5
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.84
10.28
4.5
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
13
9.99
10.01
4.8
2.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
22
7.51
9.94
1.1
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
70
345
3.03
9.61
5.4
3.0
mmol/l
2.3
2.4
0.50
64
303
(4268621)
12
14
9.27
9.49
2.4
2.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
83
457
2.96
9.20
16.8
5.5
mmol/l
1.2
1.2
0.02
78
413
(3003327) Ova and parasites identified in Stool by Light microscopy
18
35
5.74
9.15
3.5
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
18
7.85
9.00
1.2
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
15
25
6.59
8.85
3.5
1.8
mg/l
12.9
11.0
0.39
15
25
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
10
10.68
8.74
5.5
3.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
87
501
2.90
8.71
20.6
6.2
mmol/l
1.2
1.2
0.24
70
429
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
22
6.95
8.70
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
22
6.95
8.70
1.3
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
33
5.72
8.64
4.4
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
54
4.64
8.62
10.5
4.3
mmol/l
0.8
1.4
0.26
17
39
(40758558) Short blood count panel - Blood
64
315
2.88
8.61
15.5
6.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
20
7.05
8.22
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
11
9.70
8.18
6.7
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
11
9.70
8.18
6.7
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
11
9.70
8.18
6.7
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
11
9.70
8.18
6.7
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
5
23.65
8.15
1.9
8.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
156
3.18
8.08
1.8
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
24
6.36
8.02
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
12
8.89
7.67
6.7
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
12
8.89
7.67
6.7
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
42
4.76
7.46
13.8
4.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
97
3.50
7.44
1.5
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
84
512
2.57
6.96
20.9
9.6
e9/l
0.0
0.0
0.02
71
415
(40760888) Immunoglobulin light chains.free panel - Serum
10
14
7.61
6.79
11.4
3.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
53
262
2.63
6.78
7.4
4.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
12
21
6.15
6.71
1.2
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
11
9
13.12
6.70
1.6
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
13
25
5.62
6.62
1.3
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
5
19.05
6.35
1.9
1.4
%
99.4
107.2
—
9
5
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
8
13.32
6.18
1.5
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
8
13.32
6.18
1.5
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
8
13.32
6.18
1.5
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
8
13.32
6.18
1.5
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
8
13.32
6.18
1.5
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
8
13.32
6.18
1.5
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
67
385
2.40
6.09
9.9
3.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
34
145
2.77
5.71
3.2
2.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
7
13.61
5.66
4.4
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
13
29
4.83
5.64
5.2
1.2
g/l
39.8
38.0
0.41
13
24
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
21
5.59
5.62
6.5
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
8
11.90
5.37
4.4
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
36
164
2.60
5.29
3.9
1.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
6
14.02
5.14
7.0
1.2
umol/l
21.8
29.7
—
8
6
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
9
10.57
5.10
2.0
2.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
54
301
2.28
5.08
8.5
4.1
ph
7.4
7.4
0.25
14
55
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
20
5.30
4.85
1.3
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
38
185
2.44
4.83
7.1
2.6
e6/l
0.6
0.7
0.16
24
102
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
33
4.24
4.83
6.8
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
33
4.24
4.83
5.5
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
88
2.93
4.67
20.3
7.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
11
8.64
4.63
1.1
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
21
77
3.03
4.59
4.9
5.0
%
0.0
0.4
0.56
11
21
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
8
8
10.50
4.58
2.0
2.4
%
35.4
27.3
—
8
8
(3000093) Morphology [Interpretation] in Blood Narrative
8
8
10.50
4.58
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
78
2.99
4.49
5.8
5.0
%
0.0
0.3
1.76
11
24
(3017181) Myelocytes/100 leukocytes in Blood
22
84
2.92
4.48
5.6
4.9
%
0.6
1.4
1.44
12
30
(3002179) Metamyelocytes/100 leukocytes in Blood
20
73
3.02
4.40
6.2
4.9
%
0.6
0.7
—
10
20
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
245
2.22
4.39
5.2
1.9
mg/l
1.2
1.0
0.21
37
184
(3013005) Retinol [Moles/volume] in Serum or Plasma
7
6
12.18
4.32
7.7
1.2
umol/l
1.5
1.6
—
7
6
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
35
176
2.31
4.10
8.0
2.7
e6/l
1.8
2.9
0.48
22
94
(3048689) Calprotectin [Mass/mass] in Stool
32
155
2.37
4.07
3.0
2.1
ug/g
86.9
122.6
0.33
27
121
(21491868) Cryoglobulin [Mass/volume] in Serum
7
7
10.43
4.05
1.3
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
7
10.43
4.05
1.4
1.1
umol/l
15.9
14.3
—
7
7
(4062490)
8
11
7.63
3.91
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
39
211
2.17
3.82
2.0
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
45
3.34
3.76
1.5
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
27
126
2.41
3.71
3.0
1.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
7
9
8.11
3.60
1.6
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
42
239
2.08
3.59
5.0
2.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
13
6.45
3.55
1.3
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
25
115
2.42
3.54
1.9
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
50
305
1.99
3.53
11.0
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
50
308
1.96
3.41
11.1
3.1
e6/l
0.1
0.4
1.66
41
226
(3026782) Osmolality of Urine
38
212
2.08
3.41
9.3
2.8
mosm/kgh2o
599.8
570.5
0.33
33
188
(40768443) Skin Pathology biopsy report
14
49
3.06
3.30
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
33
3.53
3.26
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
61
2.83
3.26
1.7
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
28
3.77
3.26
1.4
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
52
331
1.90
3.19
5.0
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
20
4.73
3.17
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
34
3.42
3.13
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
8
7.77
3.08
1.3
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
8
7.77
3.08
6.7
1.1
umol/l
8.8
21.0
—
6
8
(3019225) pH of Specimen
21
95
2.42
3.08
20.9
3.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
21
4.50
3.05
1.7
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
9
21
4.50
3.05
1.4
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
70
2.62
3.01
3.4
3.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
35
3.32
3.00
2.0
3.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
52
2.88
2.99
2.1
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
8
17
4.92
2.96
1.6
3.8
umol/l
30.4
33.7
—
8
12
(21494434) Karyotype in Bone marrow
6
9
6.90
2.89
1.5
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
52
341
1.83
2.86
11.2
3.2
e6/l
31.1
35.6
0.15
44
258
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
42
3.03
2.82
1.2
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
58
396
1.79
2.78
12.8
3.6
e6/l
32.8
36.4
0.07
46
272
(3034426) Prothrombin time (PT)
5
6
8.58
2.77
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
15
4.85
2.63
1.4
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
20
4.17
2.61
6.0
3.6
e9/l
4.1
5.6
—
8
20
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
20
4.17
2.61
6.0
4.5
%
58.6
62.8
—
8
20
(3011397) Hemoglobin [Presence] in Urine by Test strip
41
257
1.84
2.57
5.9
3.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
7
7.35
2.57
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
91
2.26
2.46
3.0
3.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
17
4.27
2.39
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
94
756
1.72
2.38
9.8
4.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
18
4.03
2.28
1.0
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
9
5.71
2.23
1.0
1.4
ug/l
5.8
8.7
—
5
9
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
55
2.50
2.19
1.4
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
171
1.87
2.18
1.2
1.2
u/ml
1.6
8.7
—
7
67
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
19
3.82
2.18
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
19
3.82
2.18
1.4
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
88
705
1.65
2.18
7.2
4.2
—
378.8
—
0
9
(3045414) Leukocytes [Presence] in Urine
11
43
2.69
2.15
1.6
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
20
3.62
2.08
1.6
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
43
290
1.69
2.07
4.0
3.1
mg/l
151.1
290.3
0.26
30
186
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
15
4.13
2.06
3.8
3.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
42
282
1.69
2.05
1.3
1.3
u/ml
3.5
1.2
0.42
12
65
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
121
1.97
2.02
1.9
1.5
—
—
—
0
0
(44790047)
6
16
3.87
1.95
1.2
1.6
—
—
—
0
0
(44790049)
6
16
3.87
1.95
1.2
1.6
—
—
—
0
0
(44790048)
6
16
3.87
1.95
1.2
1.6
—
—
—
0
0
(44806118)
6
16
3.87
1.95
1.2
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
34
2.76
1.90
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
23
132
1.89
1.88
1.6
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
13
60
2.28
1.84
31.0
5.7
mmol/l
24.2
24.3
0.09
13
55
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
12
4.28
1.84
1.2
1.5
—
—
—
0
0
(4035726)
16
82
2.07
1.78
1.3
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
70
550
1.54
1.74
5.2
3.5
estimate
0.0
0.0
0.00
11
97
(36660697) Celiac disease serology panel - Serum
19
105
1.93
1.73
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
14
3.66
1.63
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
14
3.66
1.63
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
14
3.66
1.63
2.0
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
53
397
1.53
1.61
15.3
7.5
inr
1.4
1.2
0.42
14
115
(3012544) pH of Venous blood
19
108
1.88
1.60
22.4
4.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
39
273
1.59
1.59
2.2
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
44
2.37
1.57
2.1
2.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
33
2.51
1.56
3.5
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
35
241
1.60
1.52
7.3
6.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
137
0.41
1.50
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
16
3.20
1.45
1.4
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
42
306
1.53
1.43
4.9
4.0
mg/mmol
20.2
10.6
0.44
32
195
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
29
194
1.62
1.41
2.2
2.9
ng/l
24.5
230.1
1.65
20
143
(3000492) Spirometry study
19
113
1.79
1.40
3.1
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
23
2.68
1.38
1.8
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
67
542
1.45
1.35
5.3
3.5
estimate
0.0
0.0
—
10
99
(3019550) Sodium [Moles/volume] in Serum or Plasma
124
1138
1.71
1.30
38.1
13.5
mmol/l
139.5
139.7
0.42
118
1106
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
18
2.84
1.29
2.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
67
547
1.43
1.27
8.2
4.8
estimate
0.0
0.0
0.00
11
100
(3014007) Fractional oxyhemoglobin in Arterial blood
11
56
2.05
1.26
4.1
7.6
%
94.6
94.1
0.18
11
56
(3023103) Potassium [Moles/volume] in Serum or Plasma
124
1141
1.68
1.25
38.8
13.5
mmol/l
3.9
4.0
0.65
118
1107
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
124
1142
1.68
1.23
37.8
12.2
mg/l
16.6
22.7
2.05
107
871
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
26
2.36
1.20
1.0
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
49
384
1.42
1.14
2.6
1.8
pmol/l
81.9
95.0
1.39
32
183
(40768804) Tissue Pathology biopsy report
51
406
1.40
1.08
2.3
2.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
34
2.11
1.04
2.0
3.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
30
0.00
0.98
0.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
114
1047
1.45
0.96
26.7
11.5
ml/min/173m2
90.1
86.1
0.96
101
823
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
9
52
1.78
0.94
3.3
4.0
%
63.7
51.8
—
9
52
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
97
1061
0.73
0.93
5.0
4.1
mmol/l
6.1
5.9
0.35
89
971
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
253
1.40
0.86
1.8
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
32
406
0.73
0.82
1.9
2.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
24
0.00
0.80
0.0
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
119
1.49
0.71
2.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
156
1.41
0.66
1.6
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
21
0.00
0.60
0.0
2.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
12
81
1.53
0.59
4.1
6.3
g/l
124.8
123.7
0.06
12
76
(3019060) Gas panel - Arterial blood
9
60
1.53
0.55
2.1
3.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
6
38
1.60
0.55
1.0
1.7
mg/l
342.7
482.6
—
6
38
(3001019) Free T4 and TSH panel - Serum or Plasma
7
45
1.58
0.49
2.0
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
48
1.48
0.47
5.1
6.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
36
305
1.24
0.47
9.1
3.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
69
1.48
0.45
1.1
1.0
—
—
—
0
0
(1002224) Polysomnography panel
7
51
1.39
0.44
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
94
998
0.83
0.44
5.8
5.4
mmol/mol
39.5
39.5
0.01
87
934
(4010399)
11
78
1.44
0.44
1.7
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
125
1204
1.32
0.44
27.0
11.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
31
1.63
0.43
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
34
1.49
0.41
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
24
198
1.26
0.39
2.5
2.7
ug/l
0.7
0.7
0.21
16
126
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
35
1.44
0.39
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
35
1.44
0.39
1.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
97
1022
0.84
0.39
5.5
4.3
mu/l
2.0
1.8
0.66
92
930
(3019309) Folate [Moles/volume] in Red Blood Cells
21
171
1.27
0.38
2.0
1.7
nmol/l
1322.0
1142.8
0.40
16
125
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
9
70
1.30
0.37
1.1
1.3
—
44.5
—
0
5
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
47
1.29
0.32
3.7
3.5
u/ml
9.8
3131.1
—
6
40
(3029937) Albumin [Presence] in Urine by Test strip
33
289
1.18
0.32
4.5
3.6
estimate
0.0
0.0
0.50
11
98
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
53
493
1.12
0.22
6.2
4.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
44.2
—
0
6
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
301.0
—
0
6
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.5
—
3.2
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
483.8
—
0
6
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
2.4
—
0
5
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.2
—
4.0
—
0
5
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
10
0.00
0.21
0.0
4.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
87
834
1.11
0.21
4.7
3.7
pmol/l
14.5
14.8
0.47
81
749
(3022806) Fractional oxyhemoglobin in Capillary blood
0
13
0.00
0.21
0.0
2.6
—
91.8
—
0
13
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
51
1.18
0.19
2.0
3.2
mmol/l
24.5
24.7
—
6
51
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
107
1099
0.89
0.18
4.7
4.5
mmol/l
2.9
2.8
0.70
102
1014
(3011288) Drugs identified in Urine by Screen method
7
58
1.22
0.18
1.1
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
15
130
1.17
0.16
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
76
0.78
0.16
1.0
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
106
1086
0.91
0.16
4.4
4.1
mmol/l
4.7
4.6
0.23
101
1002
(3041096) Erythrocytes [Presence] in Urine by Automated
28
305
0.90
0.15
3.5
3.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
80
1.13
0.15
1.9
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
151
1.14
0.14
1.4
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
111
1087
1.10
0.13
36.1
12.4
%
40.2
40.7
0.38
91
851
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
115
0.86
0.11
1.5
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
102
1041
0.93
0.11
4.3
3.7
mmol/l
1.5
1.3
1.22
95
958
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
106
1080
0.93
0.10
4.4
4.0
mmol/l
1.4
1.4
1.17
100
994
(4034850)
5
43
1.17
0.10
14.6
7.7
—
—
—
0
0
(3020891) Body temperature
5
44
1.14
0.10
2.4
4.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
145
1.12
0.10
1.6
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
54
1.12
0.09
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
88
1.02
0.07
4.3
4.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
41
425
0.95
0.06
4.5
3.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
158
1.09
0.06
1.5
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
32
307
1.05
0.05
1.3
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
74
727
1.04
0.04
3.0
3.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
170
1.07
0.04
1.6
2.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
83
819
1.03
0.03
3.9
3.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
40
390
1.04
0.03
5.2
3.4
ng/l
164.7
36.1
0.69
31
252
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
15
144
1.05
0.00
1.7
1.7
%
1.6
1.4
—
10
136
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
26
266
0.97
0.00
3.2
4.0
%
22.5
22.6
0.02
16
112
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
118
1.02
0.00
12.4
6.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
95
1.06
0.00
2.0
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
71
0.99
0.00
1.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.7
—
1524.8
—
0
6
(4198724)
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.0
—
6.3
—
0
6
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.2
—
1015.8
—
0
6
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
6.7
—
0
6
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
141.8
—
0
5
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.8
—
25.8
—
0
5
(3027008) Opiates [Presence] in Urine
7
76
0.92
0.00
1.0
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
73
0.96
0.00
1.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
57
0.87
0.00
1.0
1.6
—
—
—
0
0
(44813793)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
5
59
0.84
0.00
3.8
5.4
mmol/l
23.0
24.0
—
5
53
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
80
1.00
0.00
1.4
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.0
—
222.4
—
0
5
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.4
—
0.5
—
0
5
(3010838) Calcium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.0
—
1.2
—
0
5
(3013512) EKG study
29
290
1.00
0.00
4.6
3.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.6
—
4.8
—
0
7
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
0.3
—
0
7
(3022621) pH of Urine by Test strip
7
79
0.88
0.00
2.3
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
76
0.92
0.00
1.0
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
77
0.90
0.00
1.0
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
110.9
—
0
7
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
121
1210
1.00
0.00
40.2
13.9
umol/l
81.0
76.5
0.33
121
1210
Mortality – FinRegistry
↥Association
Association between endpoint M13_SYSTCONINOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_SYSTCONINOTH | 5.224 [3.7, 7.37] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.051 |
During the follow-up period (1.1.1998 — 31.12.2019), 126 out of 560 females with M13_SYSTCONINOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_SYSTCONINOTH | 3.748 [2.61, 5.38] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 135 out of 723 males with M13_SYSTCONINOTH died.
Mortality risk
Mortality risk for people of age
years, who have M13_SYSTCONINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.508% | 0.623% |
| 5 | 2.696% | 4.136% |
| 10 | 6.368% | 10.073% |
| 15 | 12.205% | 18.83% |
| 20 | 21.608% | 30.435% |
Relationships between endpoints
↥Index endpoint: M13_SYSTCONINOTH – Systemic disorders of connective tissue in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data